Compare

Nano-X Imaging Ltd. vs Escalon Medical Corp vs Hyperfine, Inc. vs Biotricity Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNano-X Imaging Ltd.
NNOX
Escalon Medical Corp
ESMC
Hyperfine, Inc.
HYPR
Biotricity Inc.
BTCY
Year ended2025-12-312026-06-302025-12-312026-03-31
Revenue$13.02M$12.74M$13.56M$16.00M
Revenue growth (YoY)+15.4%+5.7%+5.2%+16.0%
Gross margin-98.2%43.7% (computed)49.8%80.9%
Operating margin-600.8%0.4%-273.4%10.6%
Net margin-576.1%31.5%-262.3%-15.0%
Net income-$75.02M$4.01M-$35.57M-$2.40M
EPS (Diluted)-$1.16$0.27-$0.43-$0.12
Operating cash flow-$40.79M-$402.6K-$27.95M-$719.0K
Free cash flow-$45.00M-$407.0K-$29.13Mn/a
Cash & equivalents$49.15M$3.07M$35.09M$149.8K
Total assets$162.16M$9.13M$55.26M$6.45M
Total liabilities$22.43M$3.20M$14.26M$39.41M
Shareholders' equity$139.73M$5.93M$41.01M-$34.68M
Return on year-end equity-53.7%67.7%-86.8%n/a
Shares outstandingn/a7.42Mn/a28.60M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNano-X Imaging Ltd.Escalon Medical CorpHyperfine, Inc.Biotricity Inc.
Latest$13.02M
Ended 2025-12-31
$12.74M
Ended 2026-06-30
$13.56M
Ended 2025-12-31
$16.00M
Ended 2026-03-31
1 year earlier$11.28M
Ended 2024-12-31
$12.05M
Ended 2025-06-30
$12.89M
Ended 2024-12-31
$13.79M
Ended 2025-03-31
2 years earlier$9.90M
Ended 2023-12-31
$11.98M
Ended 2024-06-30
$11.03M
Ended 2023-12-31
$12.06M
Ended 2024-03-31
3 years earlier$8.58M
Ended 2022-12-31
$12.18M
Ended 2023-06-30
$6.81M
Ended 2022-12-31
$9.64M
Ended 2023-03-31
4 years earlier$1.30M
Ended 2021-12-31
$10.70M
Ended 2022-06-30
$1.50M
Ended 2021-12-31
$7.65M
Ended 2022-03-31